News
Roche 's innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), which is playing a vital role in decoding complex diseases like cancer ...
Roche (RHHBY) unveiled its proprietary, breakthrough sequencing by expansion technology, establishing a new category of next-generation sequencing. SBX chemistry, combined with an innovative ...
The strategic collaboration with Broad Clinical Labs will explore and develop applications using Roche’s SBX sequencing technology1, with an initial focus on critically ill newborns and their ...
Roche Invests in Stratos Genomics For Further Development of "Sequencing by Expansion" (SBX) Method. Thu, 2014-06-26 16:30. Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today, it made a strategic ...
To find out more about Roche’s novel SBX technology, click here. Broad Clinical Laboratories was founded in 2013 as a subsidiary of Broad Institute, Inc. to accelerate the world toward a better ...
Roche's innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), which is playing a vital role in decoding complex diseases like cancer ...
The strategic collaboration with Broad Clinical Labs will explore and develop applications using Roche's SBX sequencing technol Tuesday, 02 January 2024 12:17 GMT عربي ...
Roche's innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), whic Tuesday, 02 January 2024 12:17 GMT عربي ...
Roche (SIX: RO, ROG; OTCQX: RHHBY) unveiled today its proprietary, breakthrough sequencing by expansion (SBX) technology, establishing a new category of next-generation sequencing. SBX chemistry, ...
Roche's innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), which is playing a vital role in decoding complex diseases like cancer, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results